CeriBell, Inc. Gross Profit
CeriBell, Inc. (CBLL) reported Gross Profit of $25.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-10
- CeriBell, Inc. gross profit for the quarter ending 2026-06-30 was $25.94M, a 38.84% increase year-over-year.
- CeriBell, Inc. gross profit for the quarter ending 2026-03-31 was $23.12M, a 28.41% increase year-over-year.
- CeriBell, Inc. gross profit for the quarter ending 2025-12-31 was $21.64M, a 33.29% increase year-over-year.
- CeriBell, Inc. gross profit for the quarter ending 2025-09-30 was $19.94M, a 32.85% increase year-over-year.
- CeriBell, Inc. gross profit for fiscal 2025 was $78.27M, a 37.93% increase from fiscal 2024.
- CeriBell, Inc. gross profit for fiscal 2024 was $56.75M, a 48.70% increase from fiscal 2023.
- CeriBell, Inc. gross profit for fiscal 2023 was $38.16M.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.94M 10-Q · filed 2026-08-10 | $49.06M 10-Q · filed 2026-08-10 | $70.70M derived: sum of 3 quarters · filed 2026-08-10 | $90.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $23.12M 10-Q · filed 2026-05-11 | $44.77M derived: sum of 2 quarters · filed 2026-05-11 | $64.71M derived: sum of 3 quarters · filed 2026-05-11 | $83.39M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $21.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $41.59M derived: sum of 2 quarters · filed 2026-02-24 | $60.27M derived: sum of 3 quarters · filed 2026-08-10 | $78.27M 10-K · filed 2026-02-24 |
| 2025-09-30 | $19.94M 10-Q · filed 2025-11-04 | $38.62M derived: sum of 2 quarters · filed 2026-08-10 | $56.63M 10-Q · filed 2025-11-04 | $72.87M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $18.68M 10-Q · filed 2026-08-10 | $36.69M 10-Q · filed 2026-08-10 | $52.93M derived: sum of 3 quarters · filed 2026-08-10 | $67.94M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $18.01M 10-Q · filed 2026-05-11 | $34.24M derived: sum of 2 quarters · filed 2026-05-11 | $49.26M derived: sum of 3 quarters · filed 2026-05-11 | $62.41M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $16.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $31.25M derived: sum of 2 quarters · filed 2026-02-24 | $44.41M derived: sum of 3 quarters · filed 2026-02-24 | $56.75M 10-K · filed 2026-02-24 |
| 2024-09-30 | $15.01M 10-Q · filed 2025-11-04 | $28.17M derived: sum of 2 quarters · filed 2025-11-04 | $40.51M 10-Q · filed 2025-11-04 | $51.63M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $13.16M 10-Q · filed 2025-08-05 | $25.50M 10-Q · filed 2025-08-05 | $36.62M derived: sum of 3 quarters · filed 2025-08-05 | $46.34M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $12.34M 10-Q · filed 2025-05-08 | $23.46M derived: sum of 2 quarters · filed 2025-05-08 | $33.18M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $11.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $20.84M derived: sum of 2 quarters · filed 2025-02-25 | $38.16M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $9.73M 10-Q · filed 2024-11-12 | $27.05M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |